In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fiscal Commission's Final Plan Includes Rebates On Drugs Used By Medicare/Medicaid Dual Eligibles

This article was originally published in The Pink Sheet Daily

Executive Summary

Commission will vote Dec. 3 on whether to approve the plan on ways to reduce federal deficits.
Advertisement

Related Content

Part D Mandatory Rebates Included In Speaker Boehner’s “Fiscal Cliff” Offer
Who’s Who On The Joint Select Committee On Deficit Reduction
Who’s Who On The Joint Select Committee On Deficit Reduction
What's Not In The Budget: Deficit Panel's Proposal For Rebates On Drugs Used By Dual-Eligibles
What's Not In The Budget: Deficit Panel's Proposal For Rebates On Drugs Used By Dual-Eligibles
Mandatory Part D Drug Rebates Proposed By Deficit Panel Leaders; Stronger IPAB Also On The Table
Mandatory Part D Drug Rebates Proposed By Deficit Panel Leaders; Stronger IPAB Also On The Table

Topics

Advertisement
UsernamePublicRestriction

Register

PS071550

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel